A new analysis of data from > 5,500 men who participated in the Prostate Cancer Prevention Trial has directly challenged the recommendation in some clinical guidelines regarding the use of PSA velocity as an indicator for immediate biopsy.
We will have more to say about this new paper by Vickers et al. once we have had a chance to review the complete article. In the meantime, here is a link to the abstract of the paper. There is already extensive discussion of this topic on many news sites, exemplified by this Reuters report on the Yahoo news site.
Filed under: Diagnosis, Risk | Tagged: biopsy, guidelines, PSA, velocity |
THE "NEW" PROSTATE CANCER INFOLINK 
Leave a Reply